Status:
UNKNOWN
Evaluation of Stendo Pulsating Suit on Microcirculation and Endothelial Function in Diabetic Patients
Lead Sponsor:
Stendo
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The action of one Stendo pulsating suit session will be evaluated on 16 type 2 diabetic patients referred on the diabetic consultations. The effects of one Stendo pulsating suit session system will be...
Detailed Description
The role of the endothelium in micro-vascular system is mediated by synthesis and release of numerous substances that act on the smooth muscle fibers. The release of these products is modulated, in tu...
Eligibility Criteria
Inclusion
- Type 2 diabetic patient
- Diagnosis of diabetes \> 1 year
- HBA1c between 6 and 8,5
- Treated with oral anti-diabetic, insulin and/or incretins which can be stayed unchanged during the 2-week study
Exclusion
- Type 1 diabetic Patient
- Antecedent of cardiomyopathy, cardiac ischemia or valvulopathy
- Severe kidney failure
- Non controlled hypertension (\> 160/100mm Hg)
- Cardiac arrhythmia
- Severe respiratory failure
- Patient with an advanced obstructive arterial disease
- Patient with a recent and progressive deep venous thrombosis
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2015
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT02293135
Start Date
November 1 2014
End Date
June 1 2015
Last Update
May 22 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Jean Verdier, Service d'Endocrinologie Diabétologie Nutrition
Bondy, France, 93143